A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056)
Clinical trial NCT01431534 · TERMINATED
Trial details
- NCT number
- NCT01431534
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-30
- Primary completion
- 2013-08-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.